| 18.04 16:01 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 18.04 16:01 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 18.04 16:01 | Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 18.04 16:01 | Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 12.04 10:37 | Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 12.04 10:37 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 12.04 10:37 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 12.04 10:37 | Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 29.02 17:26 | dpa-AFX: Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 29.02 17:26 | dpa-AFX: Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 29.02 17:26 | Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 29.02 17:26 | Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy |
| 27.02 16:01 | Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 27.02 16:01 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 27.02 16:01 | dpa-AFX: Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 27.02 16:01 | Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy |
| 18.12 10:01 | dpa-AFX: *BRYAN GARNIER CUTS VALNEVA PRICE TARGET TO 9 (13) EUR - 'BUY' |
| 18.12 10:01 | dpa-AFX: *BRYAN GARNIER SENKT ZIEL FÜR VALNEVA AUF 9 (13) EUR - 'BUY' |
| 10.11 09:12 | dpa-AFX: *VALNEVA +10,2% NACH FDA-ZULASSUNG FÜR IMPFSTOFF |
| 10.11 08:51 | dpa-AFX: *VALNEVA AUF TRADEGATE +16% - FDA LÄSST IMPFSTOFF GEGEN CHIKUNGUNYA-VIRUS ZU |
|
|
